Musculoskeletal Disorders Market Scenario | DelveInsight
How Robots Are Introducing A New Dimension To Healthcare Service Delivery
medtech-news-for-siemens-paragon-28-pulnovo-endotronix-abbott
Siemens Healthineers’s COVID-19 Antig...

Siemens Healthineers received Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test b...

medtech-news-for-cerner-scanwell-zynex-envista-sight-sciences
Cerner, Scanwell Health and Personal ...

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Ce...

medtech-news-for-neurent-theradaptive-hagar-fujifilm-brain-navi
Neurent Medical’s NEUROMARK; Brain Na...

Neurent Medical obtains FDA Clearance for NEUROMARK™, a novel multi-point Nerve Disruption Treatment...

medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign
Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ...

J&J intends to split into two companies, separating consumer products and pharmaceutical businesses  On November 12, 2021, Johnson & Johnson announced its plans to split the Company’s C...


Bone Metastasis Market
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is considered to be - the bone. Bone Metastasis occurs when cancerous cells from the primary tumor relocate to th...


myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical...


recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune
Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthrit...

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials  As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a ...


pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical
Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zi...

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone Deficiency For the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...


leading-companies-in-the-musculoskeletal-disorders-market
Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics ...

As per the WHO, “worldwide approximately 1.71 billion people have a musculoskeletal condition”. Musculoskeletal Disorders consist of over 150 conditions affecting the locomotor system of individua...


Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...